NIU IOKA – I kī a Immunocore i te Rāhina ka hokona e ia ngā hea 3,733,333 i roto i tētahi whakaaetanga pūtea haumitanga hea tūmataiti (PIPE) e matapaetia ana ka kohia he $140 miriona.
I raro i te whakaaetanga, ka hokona e Immunocore āna hea noa me ngā hea noa kāore i te pōti mō te $37.50 mō ia hea. Ko ngā kaipupuri moni o te kamupene e whai wāhi ana ki te putea ko RTW Investments, Rock Springs Capital me General Atlantic. E matapaetia ana ka mutu te whakaaetanga PIPE i te 20 o Hūrae.
Ka whakamahia e te kamupene ngā moni whiwhi hei putea i ana kaupapa here mō te mate pukupuku me te mate hopuhopu, tae atu ki te whakawhanake i tana kaupapa matua mō te mate pukupuku, arā, a Kimmtrak (tebentafusp-tebn), hei rongoā i te kiri HLA-A*02:01 pai me te mate pukupuku uveal. Ko te putea, me ngā moni whiwhi mai i a Kimmtrak, e whakaarohia ana ka putea i ngā mahi a Immunocore tae noa ki te tau 2025.
I tēnei tau, kua whakaaetia a Kimmtrak mō te whakamahi i roto i ngā tūroro he HLA-A*02:01 pai kāore e taea te tango, he metastatic uveal melanoma rānei i te US, Europe me te UK, me ētahi atu whenua. Kei te haere tonu a Immunocore ki te ako i te rongoā i roto i tētahi rangahau Wāhanga I/II i roto i te HLA-A*02:01-pai me te melanoma kiri.
Kei te whakawhanake hoki a Immunocore i ētahi atu rongoā mate pukupuku e whā, tae atu ki ētahi atu rongoā kaiwhiwhi pūtau-T e rua i roto i ngā whakamātautau Wāhanga I/II i roto i ngā pukupuku totoka matatau. Kei te whakawhanakehia tētahi o ngā rongoā mō ngā tūroro HLA-A*02:01-pai me ngā tūroro MAGE-A4-pai, ā, ko tētahi atu e aro ana ki ngā pukupuku HLA-A*02:01 me ngā PRAME-pai. E rua hoki ngā rongoā mate pukupuku kāore i te whakaaturia kei roto i te whanaketanga o mua-haumanu a te kamupene.
Kaupapahere Tūmataiti.ngā tikanga me ngā Here.Mana pupuri © 2022 GenomeWeb, he wāhanga pakihi o Crain Communications.Pūmau te mana.